In Brief: FDA appropriations
This article was originally published in The Gray Sheet
Executive SummaryFDA appropriations: Congress approves FY 1997 Agriculture Appropriations bill (HR 3603) with votes in the House and Senate Aug. 1. The measure upholds the $920.9 mil. FDA FY 1997 appropriations requested by both houses. In addition, conferees accepted a Senate Appropriations Committee proposal to require the agency to provide line-item breakdowns for spending by the commissioner's office and other centralized operations ("The Gray Sheet" July 15, I&W-10)...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.